Bupropion (Wellbutrin) is NOT appropriate for treating panic attacks and should generally be avoided in patients with panic disorder.
Bupropion is contraindicated or should be used with extreme caution in panic disorder, as it can provoke or worsen anxiety and panic symptoms due to its stimulating, activating properties. The FDA drug label explicitly warns that bupropion can cause "anxiety, agitation, and panic attacks" as neuropsychiatric adverse events 1. This is particularly concerning because panic disorder is characterized by recurrent, unexpected panic attacks—the very symptom bupropion may exacerbate.
Why Bupropion is Problematic for Panic Attacks
Mechanism of Action Issues: Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) that increases noradrenergic activity 2. This activating mechanism can trigger the "fight or flight" response that underlies panic attacks, making it fundamentally unsuitable for panic disorder treatment.
Clinical Evidence:
- One small controlled study and clinical lore have historically suggested bupropion is ineffective or potentially harmful for panic disorder 3
- A 2025 systematic review found that while bupropion may help mild anxiety in depression, its "stimulating properties can also provoke anxiety, particularly at higher doses" 2
- Recent pharmacovigilance data from the FAERS database identified panic attacks as a significant adverse event signal with bupropion 4
The Single Contradictory Study: One 8-week open-label trial (n=20) suggested bupropion SR might reduce panic symptoms 3. However, this study had critical limitations: no placebo control, small sample size, and high dropout rate (30%). This single weak study cannot override the mechanistic concerns, FDA warnings, and broader clinical experience.
What Should Be Used Instead
First-Line Treatments for Panic Disorder:
- SSRIs (sertraline, paroxetine, fluoxetine, citalopram) are the gold-standard pharmacological treatment 5, 6
- SNRIs (venlafaxine, duloxetine) are also effective alternatives 6
- These medications have established efficacy, FDA indications for anxiety disorders, and do not carry the anxiogenic risk of bupropion
When Bupropion Might Be Considered (Rare Exceptions): The only scenario where bupropion could be cautiously considered is in a patient with:
- Primary major depression (not panic disorder as the primary diagnosis)
- Comorbid mild anxiety symptoms (not panic attacks)
- Contraindications to SSRIs/SNRIs (e.g., sexual dysfunction concerns, need for smoking cessation)
- Close monitoring capability for worsening anxiety
Even in this narrow context, start at the lowest dose (150 mg daily) and monitor intensively for emergence of panic symptoms 2, 7.
Critical Monitoring Points
If bupropion is used despite these concerns:
- Week 1-2: Watch for new-onset panic attacks, increased anxiety, agitation, or insomnia
- Discontinue immediately if panic symptoms emerge or worsen 1
- Avoid doses above 150 mg daily in anxiety-prone patients
- Do not combine with other stimulating medications
Common Pitfall to Avoid
Do not confuse bupropion's role in depression with comorbid mild anxiety (where it may be acceptable) with its use in panic disorder (where it is inappropriate). The 2025 systematic review clarifies that bupropion may help anxiety symptoms in the context of depression but notes SSRIs show advantage in "highly anxious subgroups" 7. Panic disorder represents a severe, specific anxiety condition where the risk-benefit clearly favors avoiding bupropion.
Bottom line: For panic attacks specifically, choose an SSRI or SNRI. Bupropion's activating properties make it unsuitable and potentially harmful for this indication.